TD Private Client Wealth’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
TD Private Client Wealth's AMGN Position: Q1 2026 in Review
TD Private Client Wealth reduced its Amgen (AMGN) stake by 21% in Q1 2026, selling an estimated $1.72M and leaving 18,033 shares worth $6.35M. The position accounts for 0.13% of the portfolio, ranked #108.
TD Private Client Wealth first reported a position in AMGN in Q4 2019 and has held it in 26 quarters since. The position peaked at $8.82M in Q3 2023. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- TD Private Client Wealth held 18,033 shares of Amgen worth $6.35M as of Q1 2026.
- TD Private Client Wealth sold 4,826 Amgen shares in Q1 2026, an estimated $1.72M.
- Amgen made up 0.13% of TD Private Client Wealth's portfolio in Q1 2026, its #108 holding.
- TD Private Client Wealth first reported a position in Amgen in Q4 2019 and has held it in 26 quarters since.
- TD Private Client Wealth's Amgen position peaked at $8.82M in Q3 2023.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on TD Private Client Wealth's 13F filing for Q1 2026, filed 27 Apr 2026.